Plunkett Research Online: Johnson & Johnson

JOHNSON & JOHNSON (JNJ:NYS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Johnson & Johnson, founded in 1886, is one of the world’s most comprehensive and well-known researchers, developers and manufacturers of healthcare products. Johnson & Johnson’s worldwide operations are divided into three segments: consumer, pharmaceuticals and medical devices. The company’s princ.....



Johnson & Johnson
Ticker: JNJ
Exchange: NYS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 732 524-0400
Fax: 732 214-0332
Address: One Johnson & Johnson Plaza
New Brunswick, NJ 08933 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Personal Health Care & Hygiene Products
Sterilization Products
Surgical Products
Pharmaceuticals
Skin Care Products
Baby Care Products
Contact Lenses
Medical Equipment
1. Johnson & Johnson81,581,000,000
2. Roche Holding AG56,650,560,000
3. Pfizer Inc53,647,000,000
4. Novartis AG53,166,000,000
5. Bayer AG44,765,350,000
6. Merck & Co Inc42,294,000,000
7. GlaxoSmithKline plc40,864,190,000
8. AbbVie Inc32,753,000,000
9. Abbott Laboratories30,578,000,000
10. Eli Lilly and Company24,555,700,000
Contacts Description
Alex GorskyCEO/Chairman of the Board/Director
Joseph WolkCFO/Executive VP
Jorge MesquitaChairman of the Board, Divisional/Executive VP
Ronald KapustaChief Accounting Officer/Controller
Paulus StoffelsChief Scientific Officer
A. WashingtonDirector
Mark McClellanDirector
Mary BeckerleDirector
Anne MulcahyDirector
Charles PrinceDirector
D. DavisDirector
Ronald WilliamsDirector
William PerezDirector
Ian DavisDirector
Jennifer DoudnaDirector
Marillyn HewsonDirector
Thibaut MongonExecutive VP, Divisional
Ashley McEvoyExecutive VP, Divisional
Jennifer TaubertExecutive VP, Divisional
Michael SneedExecutive VP, Divisional/Other Executive Officer
Kathy WengelExecutive VP/Other Executive Officer
Peter FasoloExecutive VP/Other Executive Officer
Michael UllmannGeneral Counsel/Executive VP
Joaquin DuatoVice Chairman
Johnson & Johnson, founded in 1886, is one of the world’s most comprehensive and well-known researchers, developers and manufacturers of healthcare products. Johnson & Johnson’s worldwide operations are divided into three segments: consumer, pharmaceuticals and medical devices. The company’s princ.....
See More

Auditor: PricewaterhouseCoopers LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201820172016201520142013
Financials
    Revenue81,581,000,00076,450,000,00071,890,000,00070,074,000,00074,331,000,00071,312,000,000
    Cost of Revenue27,091,000,00025,354,000,00021,685,000,00021,536,000,00022,746,000,00022,342,000,000
    Gross Margin % - 66.8469.8469.2769.4068.67
    R&D Expense11,901,000,00010,962,000,0009,124,000,0009,270,000,0008,672,000,0008,763,000,000
    Operating Income20,049,000,00018,714,000,00021,136,000,00018,065,000,00020,959,000,00018,377,000,000
    Operating Margin % - 24.4829.4025.7828.2025.77
    SGA Expense22,540,000,00021,420,000,00019,945,000,00021,203,000,00021,954,000,00021,830,000,000
    Net Income15,297,000,0001,300,000,00016,540,000,00015,409,000,00016,323,000,00013,831,000,000
    Earnings Per Share5.700.486.045.565.804.92
    Dividends3.543.323.152.952.762.59
    Book Value Per Share24.2727.5826.7525.8627.5224.75
    Operating Cash Flow22,201,000,00021,056,000,00018,767,000,00019,279,000,00018,471,000,00017,414,000,000
    Capital Expenditure3,670,000,0003,279,000,0003,226,000,0003,463,000,0003,714,000,0003,595,000,000
    Free Cash Flow18,531,000,00017,777,000,00015,541,000,00015,816,000,00014,757,000,00013,819,000,000
Profitability
    EBITDA25,933,000,00024,249,000,00024,283,000,00023,494,000,00024,991,000,00020,057,000,000
    Return on Assets % - 0.8712.0511.6512.3810.89
    Return on Equity % - 1.9923.3721.8722.7019.92
    Net Margin % - 1.7023.0121.9921.9619.40
    Assets Turnover - 0.510.520.530.560.56
    Financial Leverage - 2.612.011.881.881.79
Brands, Divisions and Affiliates Top Salaries
Motrin
Band-Aid
Listerine
Tylenol
Neosporin
Risperdal Consta
Remicade
Orthotaxy
NameTitleSalary (US$)Bonus (US$)
Alex GorskyCEO/Chairman of the Board1,642,3080
Paulus StoffelsChief Scientific Officer1,178,3000
Joaquin DuatoVice Chairman934,0460
Sandra PetersonFormer Chairman of the Board, Divisional/Former Executive VP808,5000
Michael UllmannExecutive VP/General Counsel788,0770
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: